Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Boswellic acid, derived from the resin of Boswellia serrata (frankincense), has been traditionally used in Ayurvedic medicine, but its application for autoimmune disorders has also been the subject of scientific inquiry. The main scientific rationale for its use lies in its anti-inflammatory properties, specifically through the inhibition of 5-lipoxygenase, an enzyme involved in leukotriene synthesis, which plays a role in chronic inflammation and autoimmune pathogenesis.

Several preclinical studies and a limited number of small clinical trials have explored Boswellic acid's effects in conditions like rheumatoid arthritis, inflammatory bowel disease, and asthma—diseases with autoimmune or immune-mediated components. Some trials suggest improvements in pain and swelling in rheumatoid arthritis, and reduced inflammation in ulcerative colitis, compared to placebo. However, these studies are generally small, with methodological limitations, and often use Boswellia extracts rather than purified Boswellic acid. There is a lack of large, high-quality, placebo-controlled trials directly evaluating Boswellic acid for autoimmune diseases specifically.

In summary, while there is a plausible scientific mechanism and preliminary clinical data supporting anti-inflammatory and potential immunomodulatory effects, the overall quality and quantity of evidence remain modest. Therefore, Boswellic acid's use for autoimmune disorders is supported by limited scientific evidence, meriting a low to moderate evidence rating.

More about Boswellic Acid
More about Autoimmune Disorders

Other ingredients used for Autoimmune Disorders

Other health conditions supported by Boswellic Acid

Products containing Boswellic Acid